Niche High-Sensitivity Target DARPA and federal SBIR-style programs for ultra-sensitive detection capabilities at pg/ml levels, presenting Ionica Sciences as a specialized supplier of spectroscopic assays that can be adapted to defense and government contracts.

Point-of-Care Focus Position Ionica’s portable, low-prep assays as solutions for rapid, on-site diagnostics in healthcare, environmental monitoring, and public health, appealing to customers seeking quick turnaround without extensive lab infrastructure.

Academic Partnerships Leverage ongoing collaborations with Cornell University and City College of New York to co-develop reference platforms or grant-backed pilot programs, opening doors to university-affiliated procurement and research contracts.

Lyme and Pathogen Opportunities Explore sales avenues with Lyme disease diagnostics and other pathogen detection applications highlighted by prior partnerships, offering highly sensitive testing platforms to clinical laboratories and specialty diagnostic players.

Strategic Investment Readiness Highlight the existing SBIR funding track record and recent DARPA engagement to attract strategic investors or partners seeking capable early-stage biotech ventures with a credible government-facing roadmap and milestones.